News – Page 828 – Endpoints News

A new study points to $6.5B in public support building the scientific foundation of Gilead's remdesivir. Should that ...

5 years ago

Zai Lab inks China deal with Turning Point with $25M upfront; Xencor, Atreca team up on bispecifics

5 years ago

Singular focus on ROR1 earns VelosBio $137M to fund PhI ADC and other programs

5 years ago

Concert gets BTD for alopecia drug, setting up a late-stage showdown with giant rival Pfizer

5 years ago

'Fundamentally different' from Portola, Dutch biotech lands €32M to steer anti-anticoagulant through the clinic

5 years ago

FDA bars the door — for now — against Merck’s star cancer drug after Roche beat them to the punch

5 years ago

Biogen shares spike as execs complete a delayed pitch for their controversial Alzheimer's drug — the next move ...

5 years ago

Covid-19 roundup: Moderna sticks to July for its Phase III as rumors swirl; Following US lead, EU buys up Covid-19 ...

5 years ago

Merck dangles up to $425 million to team with Flagship’s Foghorn Therapeutics on drugging the shape of DNA

5 years ago

John Reed brings NK cells into Sanofi's CD38 rivalry with J&J — and offers thumbs up for Kiadis' new focus

5 years ago

GSK sets the stage for a toe-to-toe market showdown with Gilead's HIV champion Truvada

5 years ago

Trump and Navarro press again for hydroxychloroquine. Can the FDA stay independent?

5 years ago

Boehringer Ingelheim ties the knot with Numab on new antibodies; Cabaletta inks pact with Artisan

5 years ago

AlloVir tests how much an antiviral biotech can reap in a pandemic stock market

5 years ago

Flagship execs take a lesson from nature to master ‘gene writing,’ launching a star-studded biotech with big ...

5 years ago

Takeda’s post-merger deals continue as OTC subsidiary is prepared for sale

5 years ago

Investors give ailing Unum a lease on life and a whole new suite of experimental cancer drugs

5 years ago

OWS shifts spotlight to drugs to fight Covid-19, handing Regeneron $450M to begin large scale manufacturing in the US

5 years ago

RA Capital doubles down on Siddhartha Mukherjee's vision for a new cell engineering approach, leading Vor's $110M ...

5 years ago

Covid-19 roundup: Squabbles with government delay Moderna’s PhIII — reports; Novavax secures largest Warp Speed ...

5 years ago

Cellectis slammed after patient dies and FDA slaps a hold on their trial for an off-the-shelf CAR-T for multiple ...

5 years ago

Second PhIII study for Idorsia's sleep drug returns positive results, but also raises new questions

5 years ago

Pfizer re-ups on Mission Therapeutics collaboration, leading a $15M round and grabbing first dibs on DUBs

5 years ago

Poseida tees $150M IPO; Gilead sends HBV program back to Precision; New HIV data from Merck, Gilead

5 years ago

First page Previous page 825 826 827828829 830 831 Next page Last page